Literature DB >> 10926332

Inhaled corticosteroids and the hypothalamic-pituitary-adrenal (HPA) axis: do we understand their interaction?

P N Dekhuijzen, J W Honour.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10926332     DOI: 10.1053/rmed.2000.0791

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


× No keyword cloud information.
  5 in total

1.  Pharmacokinetics and systemic effects of inhaled fluticasone propionate in chronic obstructive pulmonary disease.

Authors:  S D Singh; C Whale; N Houghton; P Daley-Yates; S M Kirby; A A Woodcock
Journal:  Br J Clin Pharmacol       Date:  2003-04       Impact factor: 4.335

2.  Urinary pharmacokinetic methodology to determine the relative lung bioavailability of inhaled beclometasone dipropionate.

Authors:  Amira S A Said; Lindsay P Harding; Henry Chrystyn
Journal:  Br J Clin Pharmacol       Date:  2012-09       Impact factor: 4.335

3.  Adrenal axis suppression unrelated to the dynamics of dosing with beclomethasone monopropionate.

Authors:  Siobhan A Mulrennan; Joseph S Hogg; Richard C Teoh; Alyn H Morice
Journal:  Br J Clin Pharmacol       Date:  2006-09-19       Impact factor: 4.335

4.  An integrated model for the effect of budesonide on ACTH and cortisol in healthy volunteers.

Authors:  Anna Lönnebo; Anders Grahnén; Mats O Karlsson
Journal:  Br J Clin Pharmacol       Date:  2007-03-01       Impact factor: 4.335

5.  Topical corticosteroids and the risk of diabetes mellitus: a nested case-control study in the Netherlands.

Authors:  Michiel W van der Linden; Fernie J A Penning-van Beest; Tamar Nijsten; Ron M C Herings
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.